
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 23.05.2026
Invitae Corporation EBITDA per Share 2011-2026 | NVTA
EBITDA per Share Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.2 | -0.64 | -4.56 | -2.51 | -1.63 | -2.41 | -2.82 | -2.98 | -53.2 | -34.4 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.2 | -53.2 | -10.5 |
EBITDA per Share Vierteljährlich Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.19 | -0.6 | -0.56 | - | -0.78 | -10.6 | -0.81 | -0.94 | -0.62 | 0.8 | -0.49 | -1.78 | -0.44 | -0.99 | -0.92 | -0.8 | -0.69 | -0.5 | -0.41 | -0.34 | -0.28 | -0.34 | -0.61 | -0.65 | -0.52 | -0.57 | -0.61 | -0.61 | -0.62 | -0.65 | -0.74 | -0.76 | -0.59 | -0.69 | -1.03 | -16.2 | -12.4 | -11.6 | -11.4 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.8 | -16.2 | -2.25 |
EBITDA per Share anderer Aktien in der Diagnostik & Forschung
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 203.78 | -0.37 % | $ 22.6 B | ||
|
Celcuity
CELC
|
-3.68 | $ 88.24 | -4.7 % | $ 4.13 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 4.88 | 8.44 % | $ 6.49 M | ||
|
Fulgent Genetics
FLGT
|
-2.18 | $ 18.93 | 2.32 % | $ 583 M | ||
|
Castle Biosciences
CSTL
|
-0.07 | $ 21.08 | - | $ 611 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
10.5 | $ 144.59 | -4.76 % | $ 11.3 B | ||
|
Illumina
ILMN
|
6.95 | $ 162.47 | 1.52 % | $ 25.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-3.17 | $ 130.7 | 0.45 % | $ 16.4 B | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 23.46 | 3.12 % | $ 1.25 B | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.51 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 100.24 | 0.26 % | $ 6.77 B | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 186.29 | -1.88 % | $ 9.23 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.37 | - | $ 411 M | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 465.73 | -0.23 % | $ 13.4 B | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
2.48 | $ 1 133.03 | -2.58 % | $ 23.4 B | ||
|
NeoGenomics
NEO
|
-0.62 | $ 11.28 | -1.4 % | $ 1.44 B | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 4.43 | -2.42 % | $ 410 M | ||
|
National Research Corporation
NRC
|
1.35 | $ 21.28 | 7.75 % | $ 476 M | ||
|
Natera
NTRA
|
-1.96 | $ 216.5 | -2.84 % | $ 29.6 B | ||
|
Personalis
PSNL
|
-0.87 | $ 9.61 | -1.44 % | $ 858 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.69 | $ 25.67 | -3.13 % | $ 24.3 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 7.3 | -1.75 % | $ 305 M | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.02 | -1.51 % | $ 4.64 M | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 67.77 | -3.27 % | $ 4.05 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 268.63 | -0.96 % | $ 22.4 B | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 482.04 | -2.43 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.69 | 3.51 % | $ 248 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.17 | -1.29 % | $ 1.99 B |